STOCK TITAN

Enhabit SEC Filings

EHAB NYSE

Welcome to our dedicated page for Enhabit SEC filings (Ticker: EHAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Enhabit, Inc. (NYSE: EHAB) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures as a public issuer. Enhabit, which operates as Enhabit Home Health & Hospice, files reports with the U.S. Securities and Exchange Commission that describe its home health and hospice business, financial performance, governance matters, and executive compensation arrangements.

Through its Form 8-K filings, Enhabit reports material events such as quarterly earnings releases, participation in investor conferences, leadership changes, and stockholder meeting results. For example, the company has filed 8-Ks to furnish its earnings press releases and supplemental information for quarters ended March 31, June 30, and September 30, as well as to describe a CEO transition plan, retention awards for senior officers, and approval of the Enhabit, Inc. 2025 Equity and Incentive Compensation Plan at its annual meeting.

Enhabit’s filings also identify its common stock as registered under Section 12(b) of the Exchange Act and traded on the New York Stock Exchange under the symbol EHAB. The company uses its SEC reports to explain its use of non-GAAP measures such as Adjusted EBITDA, Segment Adjusted EBITDA, Adjusted EPS, and Adjusted free cash flow, and to discuss how unusual or nonrecurring items affect the reconciliation to GAAP results. Same-store comparison methodology for home health and hospice locations is also described in these materials.

On this page, users can review Enhabit’s SEC filings in chronological order, including 8-Ks that detail results of operations and financial condition, regulation FD disclosures, equity plan approvals, and stockholder voting outcomes. Stock Titan’s tools surface these documents alongside AI-powered summaries that highlight key points, helping readers quickly understand how each filing relates to Enhabit’s home health and hospice operations, capital structure, and governance.

Investors and researchers can use this filings archive to follow Enhabit’s reported net service revenue trends, segment performance, executive and director arrangements, and the regulatory context around its home-based care business, all sourced from the company’s official submissions to the SEC’s EDGAR system.

Rhea-AI Summary

Enhabit, Inc. reported that Chief Accounting Officer Collin McQuiddy sold 1,403 shares of common stock in an open-market transaction on March 11, 2026 at $13.61 per share. After this sale, he directly holds 3,991 shares of Enhabit common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Enhabit, Inc. executive Julie Diane Jolley, EVP of Home Health Operations, reported open-market sales of company common stock. She sold a total of 5,586 shares in two transactions of 2,793 shares each on March 9 and 10, 2026, at a price of $13.63 per share. After these sales, she directly holds 137,130 Enhabit common shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Marion Tanya Renee reported acquisition or exercise transactions in this Form 4 filing.

Enhabit, Inc. Chief Human Resources Officer Tanya Renee Marion reported an amended insider transaction reflecting a previously omitted stock award. On March 6, 2026, she received a grant of 10,287 shares of common stock at $13.61 per share, increasing her direct holdings to 103,339 shares. The filing also notes 1,712 shares of common stock held indirectly by her spouse. A footnote explains this award was left out of the original report due to a clerical error.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Solomon Ryan reported acquisition or exercise transactions in this Form 4 filing.

Enhabit, Inc. Chief Financial Officer Ryan Solomon reported an amended insider transaction reflecting a prior equity award. On this Form 4/A, he received a grant of 18,370 shares of common stock at $13.61 per share as compensation. After this award, he directly owns 193,911 common shares. A footnote explains the grant had been omitted from the original filing due to a clerical error, and the amendment brings his reported holdings up to date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Enhabit, Inc. executive Jeanne Louise Kalvaitis, EVP of Hospice Operations, reported an amended Form 4 reflecting a prior stock award. She acquired 6,724 shares of common stock as a grant at a price of $13.61 per share. Following this acquisition, she directly holds 61,875 common shares. A footnote explains the award was omitted from the original filing due to a clerical error, and this amendment corrects that omission.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Jolley Julie Diane reported acquisition or exercise transactions in this Form 4 filing.

Enhabit, Inc. executive Julie Diane Jolley, EVP of Home Health Operations, reported an amended insider filing reflecting a grant of common stock. She received 12,050 shares of Enhabit common stock on March 6, 2026 at a stated value of $13.61 per share as a stock award, increasing her direct holdings to 142,716 shares after the transaction. The amendment notes this award was originally omitted due to a clerical error, so the filing updates previously reported ownership rather than recording an open-market purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Black Dylan C reported acquisition or exercise transactions in this Form 4 filing.

Enhabit, Inc. reported that its General Counsel and Secretary, Dylan C. Black, received a grant of 11,463 shares of common stock on March 6, 2026 at $13.61 per share. This award increased his direct holdings to 99,823 shares of common stock. The amended Form 4 corrects a clerical error, noting that this award had been omitted from the original filing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Enhabit, Inc. executive Collin McQuiddy, the Chief Accounting Officer, reported a routine tax-related share disposition. On the vesting of restricted stock, 592 shares of common stock were withheld at $13.61 per share to cover tax withholding obligations. After this non-market transaction, McQuiddy directly holds 5,394 common shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Enhabit, Inc. Chief Financial Officer Solomon Ryan reported routine equity compensation and related tax withholding transactions in company common stock. On March 6, 2026, he received a grant of 12,859 shares of common stock at $13.61 per share as a compensation award. On the same day, 5,127 shares were disposed of at $13.61 per share to satisfy tax withholding obligations tied to the vesting of related restricted stock. On March 7, 2026, an additional 3,882 shares were withheld at $13.61 per share for tax obligations. After these transactions, he directly held 175,541 shares of Enhabit common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Enhabit (EHAB)?

The current stock price of Enhabit (EHAB) is $13.605 as of March 12, 2026.

What is the market cap of Enhabit (EHAB)?

The market cap of Enhabit (EHAB) is approximately 690.9M.

EHAB Rankings

EHAB Stock Data

690.85M
48.91M
Medical Care Facilities
Services-home Health Care Services
Link
United States
DALLAS

EHAB RSS Feed